{
    "body_text": [
        {
            "endOffset": 3556,
            "parents": [],
            "secId": "s0005",
            "sentence": "All authors declare they are employed by the GSK group of companies and hold shares in the GSK group of companies.",
            "startOffset": 3442,
            "title": "Conflict of interest"
        }
    ],
    "docId": "S0264410X17314718",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "philip.s.watson@gsk.com",
                "first": "Philip S.",
                "initial": "P.S.",
                "last": "Watson"
            },
            {
                "email": null,
                "first": "Leonard R.",
                "initial": "L.R.",
                "last": "Friedland"
            }
        ],
        "doi": "10.1016/j.vaccine.2017.10.063",
        "firstpage": "3949",
        "issn": "0264410X",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Letter to Editor"
    }
}